ArticleEquine veterinary journal2026
Seroprevalence of equine leptospirosis in Poland (2019-2023).
Article in Equine veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Seroprevalence of equine leptospirosis in Poland (2019-2023).Equine veterinary journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundLeptospirosis in horses is associated with various clinical signs, potentially leading to fatal outcomes. Additionally, the disease may pose a zoonotic risk to individuals involved in handling infected animals. Implementing a serological monitoring programme in the equine population is one of the key tools used to reduce the risk of transmission of Leptospira infections to humans.
objectivesTo provide new insights into the seroprevalence of leptospirosis in domestic horses in Poland. STUDY
designSerological monitoring program.
methodsData were collected from serological surveys of horse serum samples across 14 of the 16 provinces between 2019 and 2023. A total of 4474 horse serum samples were tested using the microscopic agglutination test (MAT), with 8 Leptospira serovars from 7 European serogroups. Statistical analyses and data visualisation were performed using Python-based libraries. Prevalence was calculated as absolute and relative percentages. Pairwise prevalence comparisons employed chi-squared tests with adjustments for multiple comparisons. Bayesian posterior probabilities were estimated to evaluate prevalence differences between groups.
resultsThe 5-year study showed a relatively high exposure (25.1%) of horses to Leptospira antigens in Poland. Dominant Leptospira serogroups were: Sejroe (39.2%), Pomona (14.6%), Bratislava (11.2%), and Grippotyphosa (10.1%). Pomorskie recorded the highest percentage of positive samples (29.2%). Conversely, Lubuskie exhibited the lowest prevalence at 16.2%. MAIN LIMITATIONS: Details on the uses of horses were not available.
conclusionsThis analysis provides valuable data on the circulation of Leptospira serogroups across different regions over time. The high seroprevalence of Leptospira in the Polish horse population underscores the necessity of ongoing monitoring, which will aid in the protection of individual horses, herds, and humans from potential infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.